` 600721 (Xinjiang Bai Hua Cun Pharma Tech Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

600721
vs
S
Shanghai Composite

Over the past 12 months, Xinjiang Bai Hua Cun Pharma Tech Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +41% compared to Shanghai Composite's 2% drop.

Stocks Performance
600721 vs Shanghai Composite

Loading...
600721
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
600721 vs Shanghai Composite

Performance Gap Between 600721 and SSEC
LOCKED
Unlock

Performance By Year
600721 vs Shanghai Composite

Loading...
600721
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Xinjiang Bai Hua Cun Pharma Tech Co Ltd vs Peers

Shanghai Composite
600721
LLY
JNJ
MRK
NOVN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Glance View

Market Cap
4.8B CNY
Industry
Pharmaceuticals

Xinjiang Bai Hua Cun Pharma Tech Co Ltd is a regional pharmaceutical company based in Xinjiang. It sells medicines, medical devices, and related healthcare products, and it also provides pharmacy and drug distribution services. In plain terms, it helps move pharmaceuticals from manufacturers and wholesalers to hospitals, clinics, pharmacies, and other healthcare buyers. The company makes money mainly by buying products from drug makers and distributors and reselling them through its own sales and distribution channels. It may also earn fees from supply-chain and pharmacy-related services tied to storage, delivery, and product handling. Its business depends on steady demand from medical institutions and everyday consumers who need prescription and over-the-counter medicines. What makes the business model different is its role as a middle link in the healthcare supply chain, especially in a large and geographically spread region. Instead of discovering drugs, it focuses on getting approved products to the places where patients and providers need them, which makes logistics, relationships with healthcare customers, and regulatory compliance central to the business.

Xinjiang Bai Hua Cun Pharma Tech Co Ltd Intrinsic Value
LOCKED
Unlock
Back to Top